Veto rights held by preferred stockholders (usually voting as a class) over specified corporate actions, negotiated in the certificate of incorporation.

Definition

Protective provisions are contractual or charter-based veto rights that require the affirmative consent of a specified percentage (often a majority) of one or more series of preferred stock, voting separately as a class or together as a single class, before the company can take certain actions. Typical protected actions include amending the certificate of incorporation, authorizing a new senior or pari passu class of stock, incurring debt above a threshold, changing the size of the board, selling or licensing substantially all assets, and effecting a merger, acquisition, or dissolution. Protective provisions are set out in the certificate of incorporation (making them enforceable against all future stockholders, not just signatories to a contract) and are a standard element of the NVCA model documents.

Why it matters

For MedTech companies, protective provisions frequently give investors control over decisions that affect the regulatory and clinical strategy indirectly, such as approving budgets for a pivotal trial, taking on venture debt to bridge to a milestone, or accepting a licensing deal with a strategic partner before a full acquisition. Founders should track exactly which actions require a preferred class vote versus only board approval, since a single blocking investor series can stall a time-sensitive transaction.

Common pitfalls

•Assuming board approval is sufficient for actions that also require a separate preferred class vote under protective provisions; closing a financing or sale without that consent can be void or subject to rescission.
•Not tracking how protective provisions stack across multiple preferred series after several financing rounds, since later series often negotiate broader veto rights than earlier ones.
•Overlooking that protective provisions typically survive and can complicate a down round or restructuring, since the very investors whose price is being reduced may need to consent to the transaction that reduces it.

Sources

NVCA Model Certificate of Incorporation · NVCA
Delaware Code Title 8, Section 242 · Delaware General Assembly
Cornell LII: Preferred Stock · Cornell Law LII

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.